Literature DB >> 12119609

High-throughput crystallography for lead discovery in drug design.

Tom L Blundell1, Harren Jhoti, Chris Abell.   

Abstract

Knowledge of the three-dimensional structures of protein targets now emerging from genomic data has the potential to accelerate drug discovery greatly. X-ray crystallography is the most widely used technique for protein structure determination, but technical challenges and time constraints have traditionally limited its use primarily to lead optimization. Here, we describe how significant advances in process automation and informatics have aided the development of high-throughput X-ray crystallography, and discuss the use of this technique for structure-based lead discovery.

Mesh:

Substances:

Year:  2002        PMID: 12119609     DOI: 10.1038/nrd706

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  105 in total

1.  Secure web book to store structural genomics research data.

Authors:  Babu A Manjasetty; Klaus Höppner; Uwe Mueller; Udo Heinemann
Journal:  J Struct Funct Genomics       Date:  2003

2.  The consequences of translational and rotational entropy lost by small molecules on binding to proteins.

Authors:  Christopher W Murray; Marcel L Verdonk
Journal:  J Comput Aided Mol Des       Date:  2002-10       Impact factor: 3.686

3.  Rapid purification and crystal structure analysis of a small protein carrying two terminal affinity tags.

Authors:  Uwe Mueller; Konrad Büssow; Anne Diehl; Franz J Bartl; Frank H Niesen; Lajos Nyarsik; Udo Heinemann
Journal:  J Struct Funct Genomics       Date:  2003

4.  Laboratory scale structural genomics.

Authors:  Brent W Segelke; Johana Schafer; Matthew A Coleman; Tim P Lekin; Dominique Toppani; Krzysztof J Skowronek; Katherine A Kantardjieff; Bernhard Rupp
Journal:  J Struct Funct Genomics       Date:  2004

5.  Celebrating structural biology.

Authors: 
Journal:  Nat Struct Mol Biol       Date:  2011-12-05       Impact factor: 15.369

6.  Efficient UV detection of protein crystals enabled by fluorescence excitation at wavelengths longer than 300 nm.

Authors:  Karsten Dierks; Arne Meyer; Dominik Oberthür; Gert Rapp; Howard Einspahr; Christian Betzel
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-03-27

7.  Commercial Licensing of HIV-1 Protease: Applications of the NIH Research Tools Policy.

Authors:  George H Keller; Steven M Ferguson
Journal:  J Biolaw Bus       Date:  2009

Review 8.  Adenylating enzymes in Mycobacterium tuberculosis as drug targets.

Authors:  Benjamin P Duckworth; Kathryn M Nelson; Courtney C Aldrich
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 9.  Strategies for targeting the cardiac sarcomere: avenues for novel drug discovery.

Authors:  Joshua B Holmes; Chang Yoon Doh; Ranganath Mamidi; Jiayang Li; Julian E Stelzer
Journal:  Expert Opin Drug Discov       Date:  2020-02-18       Impact factor: 6.098

10.  Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data.

Authors:  W Nicholson Price; Yang Chen; Samuel K Handelman; Helen Neely; Philip Manor; Richard Karlin; Rajesh Nair; Jinfeng Liu; Michael Baran; John Everett; Saichiu N Tong; Farhad Forouhar; Swarup S Swaminathan; Thomas Acton; Rong Xiao; Joseph R Luft; Angela Lauricella; George T DeTitta; Burkhard Rost; Gaetano T Montelione; John F Hunt
Journal:  Nat Biotechnol       Date:  2009-01       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.